Aspira Pathlab & Diagnostics share price stands at ₹59.35 at 17 Apr, 2026 | 15:21. The stock Aspira Pathlab & Diagnostics intraday movement has stayed between ₹55.84 and ₹59.90, while on a 52-week basis it has fluctuated from ₹49.00 to ₹81.00.
In terms of trading activity, Aspira Pathlab & Diagnostics has recorded a volume of 673 shares. The Aspira Pathlab & Diagnostics has a market cap of ₹10293000. The stock’s Average Traded Price (ATP) stands at ₹5953, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2, 5935.
The Aspira Pathlab & Diagnostics operates within a circuit range of ₹46.56-69.84 – ₹46.56-69.84, with a Value of ₹40063.69. The Delivery Percentage for the day is 74.37%. Additionally, Aspira Pathlab & Diagnostics currently falls under the No framework, and trades with a market lot size of 1.
Aspira Pathlab & Diagnostics Ltd - 540788 - Updates on Open Offer
Acquirers, through Aftertrade Broking, announced an open offer for Aspira Pathlab & Diagnostics Limited to acquire 26% of its equity shares at ₹55 per share. This cash offer values the stake at approximately ₹14.76 crores and will increase the acquirers' combined holding to 32.73% post-offer. The independent directors consider the offer price fair.
Apr 13 2026 16:04:00
Aspira Pathlab & Diagnostics Ltd - 540788 - Updates on Open Offer
Aspira Pathlab & Diagnostics' Independent Director Committee (IDC) recommends the open offer for 26,76,180 equity shares at ₹55/share as fair and reasonable, in line with SEBI (SAST) Regulations, 2011. The offer represents 26% of the company's fully paid-up equity share capital and is managed by Aftertrade Broking Private Limited.
Apr 10 2026 19:04:00
Aspira Pathlab & Diagnostics Ltd - 540788 - Letter of Offer
Acquirers and PAC launched an open offer for Aspira Pathlab & Diagnostics to acquire 2,676,180 equity shares (26% stake) at ₹55 per share, valuing the transaction at ₹14.71 crores. This offer is part of a plan to consolidate existing holdings and gain control over the target company.
Apr 07 2026 15:04:00
Aspira Pathlab & Diagnostics Ltd - 540788 - Intimation of Identified Date
Aftertrade Broking, acting as manager to the open offer, fixed March 27, 2026, as the identified date for determining shareholders. This open offer seeks to acquire a 26% stake in Aspira Pathlab & Diagnostics Limited at ₹55 per share for a total value of ₹14.72 crore.
The Buying Price of Aspira Pathlab & Diagnostics share is 59.35 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aspira Pathlab & Diagnostics stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aspira Pathlab & Diagnostics, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aspira Pathlab & Diagnostics shares is 24.97. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aspira Pathlab & Diagnostics shares is 4.74. Useful to assess the stock's value relative to its book value.
To assess Aspira Pathlab & Diagnostics’s valuation compare Sector P/E, P/B which are 52.76 & -16.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aspira Pathlab & Diagnostics is 59.91 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aspira Pathlab & Diagnostics share price is 81.00 & 49.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aspira Pathlab & Diagnostics belongs to the Healthcare sector.